The Exosome Therapeutics Market is projected to grow from $30 million in 2029 to $1.4 billion by 2040, at a CAGR of 41.1%.

The investment bank said Bio-Techne is a premium growth asset with a strong core business and growth verticals.

DATUK Dr A Jai Mohan, a dear friend and colleague, passed away in the early hours of March 13, 2025, in the presence of those who loved him much. This tribute celebrates the life and work of this ...

Indian researchers have identified some common biomarkers across different types of cancer that offer the potential of a ...

A pioneering Phase 1 clinical trial, reported in a March 9, 2025, ScienceDaily article, is advancing stem cell therapies for Parkinson's disease. After over 30 years of research, the trial reprograms ...

A new review published in Genes & Diseases on long non-coding RNAs (lncRNAs) highlights their critical role in the development, diagnosis, and ...

Multidrug-resistant bacteria pose a major threat to human health. Manipulation of bacterial genes at the transcriptional level is a potential strategy to fight antibiotic-resistant bacterial ...

Aussie country music star has chosen to undergo a double mastectomy after genetic testing revealed she shares sister’s breast cancer gene. In a social media post to her fans on Friday, the 37 ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Researchers from SRM Institute of Science and Technology, led by Dr. KN Aruljothi, have published a study in ExRNA highlighting the role of exosomal RNA (exRNA) in head and neck cancers (HNCs).